Cited by 105Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD.

Heal, D.J., Smith, S.L., Kulkarni, R.S., Rowley, H.L.·2008·Pharmacology Biochemistry and Behavior

Abstract

Attention deficit hyperactivity disorder (ADHD) is a common childhood psychiatric condition that is effectively treated by catecholaminergic drugs with a variety of different mechanisms and the SH rat is frequently used as a model of this disorder. In vivo microdialysis in freely-moving rats has been employed extensively to provide a better understanding of the pharmacodynamics of drugs at their sites of action. In this review, these three topics are brought together to explore the contribution of in vivo microdialysis studies in spontaneously hypertensive (SH) rats to our understanding of the neurochemical deficits in this rat strain and the actions of ADHD drugs on catecholaminergic function in the prefrontocortex (PFC), striatum and nucleus accumbens. What is revealed is that basal efflux of norepinephrine in the PFC is attenuated, whilst striatal and mesolimbic dopaminergic neurotransmission is hyperfunctional; the latter observation fits closely with the hyperactive phenotype of the SH rat. Furthermore, experiments performed with the enantiomers of amphetamine and threo-methylphenidate demonstrate that pharmacodynamic effects of drugs reported from experiments in outbred rat strains, e.g. Sprague-Dawleys, do not necessarily translate to the SH rat. When the findings are compared with the clinical efficacy of drugs used in treating ADHD, they indicate that the most efficacious drugs powerfully increase both norepinephrinergic and dopaminergic neurotransmission.

Integrity signals

Registry

Crossref · 10.1016/j.pbb.2008.03.016

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • SHR rats display reduced DA signaling and increased DAT expression, similar to ADHD patients.

    “Further, SHR rats display reduced DA signaling and increased DA transporter (DAT) expression, similar to ADHD patients (Russell et al., 1995; Russell, 2003; Heal et al., 2008; Roessner et al., 2010).”

    From The Effects of Methylphenidate on Goal-directed Behavior in a Rat Model of ADHD (2015) · cites this paper as Heal et al., 2008

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Heal, D. J., Smith, S. L., Kulkarni, R. S., & Rowley, H. L.
Affiliations
RenaSci (United Kingdom) (GB)
Corresponding author
Heal, D.J.
Venue
Pharmacology Biochemistry and Behavior
Publisher
Elsevier BV
Published
2008-08
Volume
90
Issue
2
Pages
184-197
ISSN
0091-3057 (ISSN-L)
OpenAlex
W2122833692
Cited by
105
References
11
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 4 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 4 · 2017: 7 · 2016: 2 · 2015: 13 · 2014: 11 · 2013: 10 · 2012: 13
FWCI
1.14
Type
journal article
Language
en
Open access
closed
Locations
  • Pharmacology Biochemistry and Behavior (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Shire
  • National Institutes of Health
  • National Institute of Mental Health
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
attention deficit hyperactivity disorder, spontaneously hypertensive rats, in vivo microdialysis, pharmacodynamics, norepinephrine efflux, striatum, nucleus accumbens, dopamine signaling, hyperactivity, animal model of ADHD
MeSH terms
Atomoxetine Hydrochloride, Amphetamine, Animals, Attention Deficit Disorder with Hyperactivity, Disease Models, Animal, Dopamine, Humans, Methylphenidate, Norepinephrine, Propylamines, Rats, Inbred SHR, Rats, Inbred WKY, Microdialysis, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review